Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 134, Issue 1, 2007, Pages 188-193

  Uy, Karl L ^a   Darling, Gail ^a   Xu, Wei ^a   Yi, Qi Long ^a   De Perrot, Marc ^a   Pierre, Andrew F ^a   Waddell, Thomas K ^a   Johnston, Michael R ^a   Bezjak, Andrea ^a   Shepherd, Frances A ^a   Keshavjee, Shaf ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MALE; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; TUMOR BIOPSY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DISEASE-FREE SURVIVAL; ETOPOSIDE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PREOPERATIVE CARE; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 34250743181     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.01.078     Document Type: Article

References (21)

1. Martini N., Kris M.G., Flehinger B.J., et al. Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann Thorac Surg 55 (1993) 1365-1374
2. Roth J.A., Atkinson E.N., Fossella F., et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 21 (1998) 1-6
3. Rosell R., Gomez-Codina J., Camps C., et al. Preresectional chemotherapy in stage IIIA non-small cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 26 (1999) 7-14
4. Depierre A., Milleron B., Moro-Sibilot D., et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 20 (2002) 247-253
5. Johnstone D.W., Byhardt R.W., Ettinger D., and Scott C.B. Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Int J Radiat Oncol Biol Phys 54 (2002) 365-369
6. Albain K.S., Swann R.S., Rusch V.R., et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): outcomes update of North American Intergroup 0139 (RTOG 9309). Proc Am Soc Clin Oncol (2005) abstract 7014
7. Daly B.D., Mueller J.D., Faling L.J., et al. N2 lung cancer: outcome in patients with false negative computed tomographic scans of the chest. J Thorac Cardiovasc Surg 105 (1993) 904-910
8. Keller S.M., Vangel M.G., Wagner H., et al. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. J Thorac Cardiovasc Surg 128 (2004) 130-137
9. Roth J.A., Fossella F., Komaki R., et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA nonsmall cell lung cancer. J Natl Cancer Inst 86 (1994) 673-680
10. Rosell R., Gomez-Codina J., Camps C., et al. A randomized trail comparing preoperative chemotherapy plus surgery with surgery alone in patients with nonsmall cell lung cancer. N Engl J Med 330 (1994) 153-158
11. Depierre A., Milleron B., Moro-Sibilot D., et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N00, II, and IIIA nonsmall cell lung cancer. J Clin Oncol 20 (2002) 247-253
12. The International Association for Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350 (2004) 351-360
13. Douillard J.Y., Rosell R., De Lena M., et al. ANITA:phase III adjuvant vinorelbine and cisplatin versus observation in completely resected non-small-cell lung cancer patients: final results after 70-month median follow-up. Lancet Oncol 7 (2006) 719-727
14. Voltolini L., Luzzi L., Ghiribelli C., Paladini P., Di Bisceglie M., and Gotti G. Results of induction chemotherapy followed by surgical resection in patients with stage IIIa (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy. Eur J Cardiothorac Surg 20 (2001) 1106-1112
15. Wada H., Nakamura T., Nakamoto K., Maeda M., and Watanabe Y. Thirty-day operative mortality for thoracotomy in lung cancer. J Thorac Cardiovasc Surg 115 (1998) 70-73
16. Fang D., Zhang D., Huang G., Zhang R., Wang L., and Zhang D. Results of surgical resection of patients with primary lung cancer: a retrospective analysis of 1,905 cases. Ann Thorac Surg 72 (2001) 1155-1159
17. Ginsberg R.J., Hill L.D., Eagan R.T., et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 86 (1983) 654-658
18. Stamatis G., Djuric D., Everhardt W., et al. Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients. Eur J Cardiothorac Surg 22 (2002) 292-297
19. Martin J., Ginsberg R.J., Abolhoda A., et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 72 (2001) 1149-1154
20. Doddoli C., Barlesi F., Trousse D., et al. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits. J Thorac Cardiovasc Surg 130 (2005) 416-425
21. Van Schil P., Van Meerbeeck J., Kramer G., et al. Morbidity and mortality in the surgery arm of EORTC 08941 trial. Eur Respir J 26 (2005) 192-197